CNTB — Connect Biopharma Holdings Ltd

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1835268 ·
Last close
$0.58
Market Cap
$36.45M
52W High
$3.82
52W Low
$0.55
ADV30
815,824
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 2,768,000 — -17,604,000 -17,284,000 43,472,000 27,015,000 16,611,000
Mar 2026 169,000 — -19,607,000 -19,398,000 60,066,000 46,034,000 17,443,000
Dec 2025 0 — -15,526,000 -15,109,000 56,075,000 38,345,000 14,095,000
Sep 2025 16,000 — -17,677,000 -17,200,000 67,361,000 37,845,000 11,990,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-60,583,000
Investing CF
$26,861,000
Financing CF
$19,879,000
CapEx
$-434,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.19
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-437,517,000
Inventory
—
Receivables
$2,958,000
ST Investments
$4,471,000
EBIT TTM
$-70,414,000
Pretax Income TTM
$-68,795,000
Interest Exp TTM
—
Analysts
7

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,953,000
EBITDA
$-69,729,000
Free Cash Flow
$-34,712,752
Enterprise Value
$97,577,592
Total Cash
$31,486,000
Total Debt
$596,000
Shares Out
62,974,309
Trailing EPS
$-1.19
Book Value
$0.43
ROE
-140.5%
ROA
-69.7%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 64,000 -58,074,000 -55,480,000 56,075,000 14,095,000 41,980,000 -51,206,000
Dec 2024 26,033,000 -22,452,000 -15,628,000 101,284,000 9,118,000 92,166,000 -23,612,000
Dec 2023 0 -69,056,000 -62,106,000 127,375,000 25,878,000 101,497,000 -47,741,000
Dec 2022 0 -116,507,000 -118,091,000 174,013,000 16,521,000 157,492,000 -101,520,000

TTM Snapshot

Revenues TTM
$2,953,000
NetIncome TTM
$-68,991,000
OpCashFlow TTM
—
Assets (Latest)
$43,472,000
Forward EPS
$-0.75

Peers — same industry

TickerNameMarket CapLastDaily %
VERU VERU INC. $36.49M $2.14 —
SER Serina Therapeutics, Inc. $36.27M $1.37 —
GRCE Grace Therapeutics, Inc. $36.18M $1.72 —
BMEA Biomea Fusion, Inc. $35.47M $0.49 —
OSTX OS Therapies Inc $34.86M $0.74 —

News headlines (Yahoo Finance, 1h cache)

Connect Biopharma Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-16 21:05 · Yahoo
Connect Biopharma Holdings (CNTB) Stock Sees Modest Fair Value Lift After Trial Driven Revisions
2026-11-11 04:35 · Yahoo
Down 25.4% in 4 Weeks, Here's Why Connect Biopharma Holdings (CNTB) Looks Ripe for a Turnaround
2026-10-22 12:35 · Yahoo
Here's Why Connect Biopharma Holdings (CNTB) Could be Great Choice for a Bottom Fisher
2026-10-19 12:55 · Yahoo
Connect Biopharma COPD Study Shows 81% Cut in Treatment Failures
2026-10-04 07:02 · Yahoo
Connect Biopharma Reports Positive Phase 2 Rademikibart COPD Data, Plans FDA Talks on Phase 3 Program
2026-09-30 14:43 · Yahoo
Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation
2026-09-30 11:00 · Yahoo
Connect Biopharma (CNTB) Misses Key Asthma Trial Goal. Can its Drug Still Move Forward?
2026-09-22 23:45 · Yahoo
Connect Biopharma Rademikibart Phase 2 Data Shows Lung Function Improvement but Primary Endpoint Misses Significance
2026-09-15 15:01 · Yahoo
Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-03 20:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.